 The next item of business is members' business debate on motion 13860 in the name of Clare Adamson on pancreatic cancer awareness. The debate will be concluded without any questions being put. Would those members who wish to speak in the debate please press the request to speak buttons and can I remind those in the public gallery that we would appreciate no clapping or jeering or other rise? I would ask Clare Adamson to open the debate please for around seven minutes. I thank my colleagues from across the chamber for supporting the motion and allowing this member's debate to take place. It is the second debate raising the issue of pancreatic cancer in the chamber. It is a way of recognising the tireless work of those involved in pancreatic cancer UK and pancreatic cancer Scotland who support people who have been touched by those diseases in our country. I was very honoured to host the event last night jointly from both charities and meeting many of the people who have been affected by pancreatic cancer, those who are dedicated to fundraising, those who are raising awareness, those who are doing research and, of course, supporting those who have been affected by their families and friends suffering from this disease and also to meet some of the survivors. We attend many such events in this place but what was quite noticeable last night is how few survivors are in attendance. Only one person in the room had survived pancreatic cancer by more than 10 years and they are known as the 1 per cent club in the pancreatic community. Those are stark figures that have hardly changed in the last 50 years and that is why we all have to work together in Scotland to make breakthroughs and lead in this area. It was delighted that it was also in attendance last night when the young leaders from the Precision Panc research team at the Beatson research centre were funded by Cancer Research UK and the Scottish Government that seeks those vital breakthroughs in pancreatic cancer. Why is that so important and so unique? The five-year survival rate for Scotland is 5.6 per cent and that has only increased by 2.1 per cent in the last 20 years. There were 784 people diagnosed with pancreatic cancer in 2016, 719 people died of this illness the same year. 9.2 per cent of patients diagnosed with pancreatic cancer distal bile or retract or duodenal cancer in Scotland have potentially curative surgery in 2016, only 9.2 per cent. 63 per cent of people with pancreatic cancer are diagnosed at stage 3 or stage 4, the advanced stages of the disease. 80 per cent of the people with pancreatic cancer are not diagnosed until the cancer is at the advanced stages. Surgery is the only treatment that can save lives, yet only 8 per cent of the people with pancreatic cancer reach the surgery stage. Pancreatic cancer UK has stressed and the many members and the families that I have met, especially the Begley family and Mr Begley's daughter Linda Bunny, have stressed that pancreatic cancer must be treated as an emergency and oncological emergency. It is the quickest killing cancer and many people diagnosed die within a month of their diagnosis. So many days and hours in this disease are as weeks and months and years in other cancers, and it is why it is so unique and why we need a very specific approach to it in Scotland. We are lucky in Scotland in that a 15 per cent target already exists as part of the quality improvement indicators in trying to get people through surgery and through treatment, and that is being achieved in some of our health boards, and it would be very, very welcome if that target could be achieved across the board when it comes to pancreatic cancer. It is a very tough disease to diagnose. The presentation of the symptoms can be seen as something else. It involves stomach pain, back pain. You cannot touch a pancreatic cancer, you cannot feel a lump or a change in your body apart from the symptoms the way other people have had this change in the bowel movements, change in bowel smell, change in those areas. People have been working really, really hard to alert people to the symptoms of pancreatic cancer. I know that there is a pancan van—we have all got that right—that has been going around. It is pancreatic cancer Scotland who have been doing what they call their thistle stop tour of Scotland—very appropriate since they have a thistle on their logo for pancreatic cancer Scotland. It is being going into our town centres—they were on the high street today—taking the message about being wary of the symptoms, people knowing what to look for and for seeking advice and treatment as quickly as possible for this. I would also like to thank the many, many organisations and councils that have supported the light up purple for this month of pancreatic cancer awareness. We had the Kelpies lit up, we have had major buildings across Scotland including the Scottish Parliament support, the light up purple challenge. This is a really unique and devastating cancer. One of the asks from the cancer charities is that a review of the pathways in Scotland is undertaken and that a review of treatment pathways will be considered by the Government. I know that the Government is doing a cancer review in general at the moment but it would be interesting to see what features of pancreatic cancer that are unique to that disease will be considered in looking at the pathways forward. I will be really interested to know the benchmarking that the Government will use to note that we have progress in that area. We now move to the open debate. Speeches of around four minutes, please. Miles Briggs, followed by Bill Kidd. Thank you, Deputy Presiding Officer. I am pleased to take part in today's debate. I would like to start by welcoming all those who have joined us this evening in the public gallery. To start by congratulating Clare Adamson on securing today's debate and recognising her consistent interest in campaigning and involvement in the issue, I think that it is important in those debates that we recognise members who are using their time in this Parliament to really progress issues. Clare is certainly one of those people. I would also like to thank Pancreatic Scotland, Pancreatic Cancer UK for providing useful briefings for today's debate, as well as those constituents who have contacted me here in Lothian, who have lost members of their family, who have dedicated their life now to making sure that we focus on trying to take forward any actions that we can. I want to begin today by agreeing with the motion's content, praising those for the excellent pancreatic cancer charities that we have and their supporters and the need to progress early detection and diagnosis. As Clare Adamson rightly stated, only 17 per cent of people with pancreatic cancer are diagnosed at stage 1 and 2, with 63 per cent of people diagnosed at stage 3 or 4 advanced stage. We must work to make progress to change that. Pancreatic cancer is the fastest-killing cancer, and if nothing changes, it is set to be the fourth biggest cancer killer in the UK by 2026. As well as improving early detection, we need to see far swifter treatment after diagnosis, something that Pancreatic Cancer UK is right to be campaigning so strongly on. Only 9 per cent of patients diagnosed with pancreatic cancer or diodino cancer in Scotland had potentially curative surgery in 2016, and only 2 in 10 received chemotherapy. A model of fast-track surgery in Birmingham has demonstrated that an additional 20 per cent of people can have surgery if treated within the 20-day period. That means that, for Scotland, more than 200 extra people could survive every year for beyond a year. I have talked about this and the need for ministers to look towards developing a fast-track model in the chamber before. I hope that we will see ministers, when they respond to this debate, look to how we can change this and how plans are being taken forward in this area. Similarly, for those with late stage cancer, the model at the Clatterbridge Cancer Centre in Merseyside demonstrated that, if individuals are treated quicker, 25 per cent more can receive chemotherapy, and we need to see if we can replicate this best-practice model here in Scotland. I recently had the pleasure of visiting Pancreatic Cancer UK's Future Leaders Academy, a training programme based at the Beatson Institute in Glasgow. I was delighted to be joined on that visit by Kim Rowan, who I know is in the public gallery with us this evening, and who really is an inspirational, dedicated pancreatic cancer campaigner and is well known to many MSPs in the chamber for her significant contributions to our cross-party group on cancer. On that visit, I was incredibly impressed by the work being undertaken by Professor Owen Sampson, director of the Cancer Research UK Beatson Institute and the Pancreatic Cancer Future Leaders Academy, and his highly talented team of researchers. Their truly groundbreaking research, I do believe, offers real hope for the future. The young researchers working there may well become world-leading scientists, bringing the breakthroughs of the future to fruition. We are expecting great things from them, and I hope that they will deliver on that. One issue that was raised with me on that visit was that of protected research time and research work. I wonder if the minister has any comments on that when she is closing the debate. If the minister would be willing to look into those concerns that have been raised, I am happy to write to her about them. I am whether or not they are aware of cancer research UK have said in terms of welcomed increase capacity in this area. I think that the research work that clinicians could do to complement the future leader programme is something that we should all be working for. More broadly, it must be a concern for all of us that pancreatic cancer is historically underfunded in the UK, receiving only 1 per cent of cancer research budget over the past decade. To conclude, Deputy Presiding Officer, I again very much welcome to today's debate. I am willing to be part of playing my role and I hope that the whole Parliament's role in raising awareness of pancreatic cancer and the need to improve diagnosis and treatment. Charities such as pancreatic cancer UK have set out positive and specific measures that we could now do to take forward a real difference in life expectancy. I hope that ministers will take a decisive lead to look at how we can take those forward to provide and extend lives. Last night, as Clare Adamson mentioned, I was filled with hope to meet so many people. At long last, we can hopefully see an opportunity to make a real breakthrough. I hope that we can all work towards achieving that in the future. Bill Kidd, followed by Monica Lennon. Thank you very much, Presiding Officer. A big thank you to Clare Adamson for bringing this debate to Parliament. This debate, as it is in the middle of pancreatic cancer awareness month, is timely and very important. I am going to say a few things that have been said already, unfortunately, but it cannot be done with being as much emphasis on it as possible, is the fifth most common cancer in Scotland. Of the 20 most common cancers in Scotland and the UK, it has sadly the lowest survival rate. Survival of this disease has hardly improved since the 1970s, and very sadly one in four will pass away one month after diagnosis. Out of all research into the different types of cancer, pancreatic cancer only receives 1.9 per cent of the annual UK cancer research budget, and pancreatic cancer UK emphasises that that has resulted in a lack of breakthroughs in understanding the disease better and developing new breakthroughs. That is an extremely serious and fast-killing disease, and we need to do everything in our power to tackle that. Charities are a critical player in that fight. One example that I would like to mention has been mentioned already comes from the Future Leaders Academy at the Cancer Research UK Beaks and Institute, which is based on my constituent, Glasgow Anisland and also in Bersden, Mogai. A substantial grant of £625,000 is funding four years of research focused specifically on pancreatic cancer. To this end, the charity Pancreatic Cancer UK recruited five PhD students to conduct that research. It provides a basis for hope that there will be vital breakthroughs in understanding and treating the disease. By deepening the scientific understanding of how cancer grows and how it resists current treatments, there is the potential for the research to show ways of targeting those two processes. That could enable the development of treatments that slow down or even halt the disease. Alongside the line of research, the team is always looking into ways to wake up the body's immune systems to help it to fight the disease. Aside from that boost to research, public awareness of the disease and of prevention is also vital. Cancer Research UK reports that 31 per cent of pancreatic cancer cases are preventable, which emphasises to me how important public awareness is. Ash Scotland highlights that smoking causes 22 per cent of cases of pancreatic cancer and that the risk doubles among people who smoke. However, after someone stops smoking, that risk decreases over time. Research shows a correlation of higher rates of cancer amongst poorer communities. As smoking is more prevalent in poorer areas, it is particularly important that health professionals inform people living in those areas about those risks. That message needs to reach everyone. It is so important that Scotland changes the way that we respond to cancer by adopting healthier lifestyles. That is something that we all should take on board. We must hold on to the knowledge that investment into research will provide medical breakthroughs, and the boost to research happening in Glasgow provides hope that the devastating statistics that we have heard about will be turned around. Beyond that, the work done daily by charities to provide emotional, practical and financial support to people affected by cancer gives people dignity and a lifeline amidst what must be one of the most difficult things that they and their loved ones have had to face. I will close by asking those listening to consider giving to pancreatic cancer charities, whether it is a one-off donation or a monthly giving basis. Every pound donated will go towards saving lives and giving hope. I thank Clare Adamson for not only bringing the debate forward and securing cross-party support, but for being a champion and for speaking so movingly about the issue. I welcome people in the gallery. It is nice to see a splash of purple across the Parliament. I thank Clare for the ribbon badge that was handed to me just a few minutes before we started. Reading the briefings that have come in from pancreatic cancer UK, McMillan Cancer, Cancer Research UK and Pancreatic Cancer Scotland, when you stop to read the briefings and read the statistics, is terrifying. That could be a very, very bleak and negative debate. Pancreatic cancer is a cancer emergency. We know that it is tough to diagnose, it is tough to treat and it is tough to survive. It must be simply terrifying to receive that diagnosis or to be a loved one of a person who has had that diagnosis. In reading the national picture, I was quite troubled to learn that in Lanarkshire, where I represent constituency central Scotland, there is a higher incidence of pancreatic cancer in Lanarkshire. I know that that is something that Clare Adamson will also be concerned about, and I would like to try to understand that a bit better. In all those situations, we have to try to look at the human story behind these statistics. Just today, I picked up one of my local newspapers, the East Kilbride News, and there was a story about Kenny Forbes, a local man who was diagnosed with pancreatic cancer. His story is a hopeful story. He has described himself as one of the lucky ones, which is not what you expect people with pancreatic cancer to say, but he has been able to be treated for his cancer and, according to his story, he has made a full recovery and is back at work as an electrician. That has to give his hope. I am also mindful that it is round about the anniversary of my neighbour, who sadly died of pancreatic cancer this time last year. A neighbour whom I would often meet in the driveway when he was coming home from work talking about his family and for him to be diagnosed within a couple of months to have lost his life is very sad. We know that cancer is preventable. We have a big job to do across the Parliament working together, but when you hear Kenny's story, it gives hope. I was not aware of the Begley family story, but I thank you to Claire Adamson for shining a light on that. Although, sadly, Mr William Begley passed away, Linda and the family have been absolutely tenacious in their campaigning and it keeps us and the Parliament completely focused. There are some positives that are clear. I have not talked about the quality performance indicator. Again, there is some success there, but I was quite concerned that there has been a bit of a rollback in some of that progress. The latest figures that we have show that the target was only met in Lanarkshire and perhaps the minister in her closing remarks will touch on that issue around the QPI and why we have had that dip in performance and what we can do to bring that back up again. I do not think that we can repeat enough that with pancreatic cancer we are facing a cancer emergency. Faster treatment is vital to increase people's chances of survival. A lot of good suggestions have come forward from campaigners. Miles Briggs has touched on that, and I think that focusing on the beats and the opportunity that we have with that centre of excellence. No pressure on these young researchers, we have high expectations, so we have to make sure that they are properly resourced. Bill Kidd rightly mentioned the wonderful funders that goes on in communities and from families. People with that lived experience, but we cannot leave that burden just to charities and to people who have that generosity of spirit. We have to make sure that we do all we can to prevent ill health, to help people to live healthier lives. However, when people get those diagnoses, they can have hope that they can survive and live well after cancer. Maureen Watt followed by Annie Wells. Thank you very much, Presiding Officer. I thank Clare Adamson for bringing this motion to Parliament for debate this evening. I apologise for not being able to attend the pancreatic cancer awareness event last evening. I was, however, able to visit the pancan van, which I think was generously provided by the Arnold Clark organisation when it visited Aberdeen St Nicholas Street on Monday 12 November. I really have to pay tribute to the three brave souls who endured a particularly cold day to hand out leaflets to raise awareness of the symptoms and the risks associated with pancreatic cancer. They were telling me that there was genuine interest among the members of the public who came and spoke to them. Of course, they were able to answer questions around pancreatic cancer. It is great that, during this month, the pancan van has been out around the country to raise awareness. I also recommend the pancreatic cancer Scotland's website for the wonderful information that they have on the disease. The little leaflet that they were giving out during their visits to the cities around Scotland was very informative. I do not think that I myself had made the connection between the pancreas, which I normally think of producing the juices, which help to digest food. It is also, of course, the organ that produces insulin, which we all know is really important in terms of blood sugar levels. We get a lot of information about obesity and diabetes, but I have not really understood the significance of it in relation to pancreatic cancer. It is disappointing that still the causes of the majority of pancreatic cancer cases remain unknown, although we do know that, as with other cancers, being overweight, smoking, diabetes and the family history of the cancer may all be contributing factors, as is having experienced pancreatitis. As others have said, the cancer, unfortunately, has the lowest survival rates, and those numbers have barely changed over the last five decades. That is not just in Scotland but elsewhere, because I am sure that, if progress was made anywhere else in the world, it would be adopted in Scotland and elsewhere as quickly as possible in order to have better outcomes. It is really essential that people know the signs of possible pancreatic cancer and that they are widely recognised, so that the earliest possible diagnosis and treatment can begin. I agree with others who have said that treatment should begin as quickly as possible for that particular cancer, because we know that it can have a good outcome, especially if it has not spread to other organs and that people can have a particular procedure. The pancreatic cancer Scotland's website says that, and I quote NHS treatment in Scotland, it is as good as anywhere in the world, and patients can rest assured that they will be looked after properly. As someone else said, it is absolutely vital that people have the support of family and friends and that they know what to do. Of course, that is where other organisations come into being, such as McMillan, Marie Curie and Maggie's cancer centres, all of which are active in Aberdeen and elsewhere. There is a Facebook group that people who have had the operation can join, which is called the Whipple Warriors, and they can share their experiences and advice. I found out that that is apparently called after the name of the procedure, which is called the Whipple Procedure. I wonder whether that is what Miles Briggs has visited, because there is research being carried out in Scotland and elsewhere and a lot in the Wilson Institute and funded by the Institute, which is called Precision Panc. That is to improve the diagnosis and treatment, and increasingly it is using the understanding of genome sequencing, again where Scotland is world-leading in diagnosing it. I am sure that everyone here wishes that there is a breakthrough in early diagnosis and treatment of this terrible disease. The last of the open debate contributions is from Annie Wells. I, too, want to thank Clare Adamson for bringing this debate to the chamber today and for her continued passion and commitment to the cause. Unfortunately, I could not be there last night, but I was there last year, and we spoke last year at the event as well. My sincere thanks to Clare. Last Thursday marked the world pancreatic day in this month, pancreatic awareness month. More than 50 per cent of patients have never heard of pancreatic cancer before their own diagnosis, and half the population cannot name a single symptom of pancreatic cancer, which makes raising awareness all the more important. That is a great opportunity to thank the pancreatic cancer charities, who work extremely hard to do this and to further support their work. Often during members' debates, when I actually learn about health conditions that I have not had the personal experience of, this one is no exception. Prior to this debate, I was not aware that pancreatic cancer is one of the least survivable cancers, and the fifth most common cause of cancer death in Scotland. Nor was I aware that pancreatic cancer has an extremely low survival rate, between 3 and 6 per cent. Often, that is due to late diagnosis, as we have heard, and there are currently no screening or early detection tests, and as many as one in four people can die within a month of diagnosis, many not receiving any active treatment at all. Early detection is vital to improving a person's chance of survival, and currently, symptoms are not known well enough. It is estimated that 70 per cent of patients with pancreatic cancer will go to the doctor initially due to pain, often described as being in the stomach carrier and radiating around the upper back as the tumour presses against the abdomen and spine. Many people I imagine will not have anticipated their diagnosis, making raising awareness even more important. Through engaging with local communities to help people to identify key signs and symptoms of pancreatic cancer and to raise the money needed to research early diagnosis, pancreatic cancer charities need our support. During pancreatic awareness month, charities have campaigned for people to wear purple to help to raise awareness and to help to create a discussion, which is why I have dug out the only purple top that I own—probably not the most suitable for the chamber, but yes. In Glasgow, the Queen Elizabeth hospital, the Silverburn shopping centre and Mosshight flats have all been lit up this month to show support. All year-round charities such as Pancreatic Cancer Action offer awareness talks at workplaces and the resources for individuals to set up awareness stands in supermarkets, community centres and in GP surgeries. Now that I am aware of such initiatives, I will do my best as an MSP to spread the word through social media and encourage others to do the same. Faster treatment is of course key to more people surviving pancreatic cancer. Pancreatic Cancer UK has described it as a cancer emergency, as we have heard from Monica Lennon. Calling for people with pancreatic cancer to be treated within 20 days from diagnosis is something that I would wholeheartedly support. Research into pancreatic cancer is also vital. As an MSP for Glasgow, I too want to highlight cancer research UK's £10 million investment into the pioneering project, PrecisionPanc, which is led by a clinical trials unit at Glasgow's Beaks in West of Scotland Cancer Care Centre and aims to transform pancreatic cancer trials in the UK. To finish today, I thank Clare Adamson for highlighting an extremely important topic, as well as the pancreatic cancer charities that work tirelessly to raise awareness of the condition and raise the funds needed to find early detection tests that are so desperately needed. With one person dying every hour in the UK due to pancreatic cancer, the need for us all to raise awareness of this disease has now been more pertinent. I thank Clare Adamson for bringing this important debate to Mark pancreatic cancer awareness month. I would also like to welcome the visitors to the gallery, as Monica Lennon said. It is a lovely splash of purple in the chamber. I thank members for their very measured and considered contributions from right across the chamber this evening. They have highlighted the importance of the charities' work and how vital research is in finding cures and treatments for this disease. There have been many mentions of the Beats in Glasgow this evening in the research that they do. My family, too, have been affected by this terrible disease. I would also like to thank Pancreatic Cancer UK and Pancreatic Cancer Scotland for the vitally important work that they do supporting those affected by pancreatic cancer, their families and their loved ones. I am particularly proud of the work done by my constituent Fiona Brown of Pancreatic Cancer Scotland, who is incredibly passionate about raising awareness. As we all know, November marks pancreatic cancer awareness month and I know that both organisations have been working hard. The parliamentary reception yesterday, attended by my colleague Jo Fitzpatrick, was a great success and I know that he was impressed with what he heard. Another such event is the tour of the pancan van, which has been driving the length and breadth of Scotland to raise awareness of the risks and symptoms of pancreatic cancer. Today, the purple van was on the royal mile, bringing awareness right to our doorstep. As we have heard from other members, across Scotland, public buildings have been bathed in purple light and tribute to those affected by this disease. I am happy to say that the Scottish Government contributed to this awareness by lighting up St Andrew's house and Victoria Key Purple last Thursday. The Scottish Government recognises the devastating impact of all cancers, including pancreatic cancer, on individuals, their family and friends. However, it is also right that we should recognise where progress has been made. Over the past 10 years, the overall age-adjusted cancer mortality rate in Scotland has reduced by 10 per cent. That is a great improvement and is testament to the amazing efforts of all those working across the NHS and the third sector. Patients and their families lie at the heart of all our efforts to tackle cancer because it is the human story behind the statistics that matter most. It is for this reason that I also want to mention Linda Murray, whose father, William Begley, passed away from pancreatic cancer. I believe that she is here today in the gallery, along with my constituent Fiona and others who have been affected by this terrible disease. Linda kindly developed a comprehensive and detailed report outlining her pancreatic cancer journey and has continued to engage with Scottish Government ministers and officials to improve care for those affected by pancreatic cancer. There are certainly many lessons to be learned for all of us delivering cancer services in Scotland, not least around putting the patient voice, their wishes and those family members and loved ones to the forefront. In March 2016, the Scottish Government unveiled its ambitious and wide-ranging cancer strategy, beating cancer ambition and action, which serves as a blueprint for the future of cancer services in Scotland. Over the coming years, the cancer strategy will deliver £100 million of investment to improve the prevention, detection, diagnosis, treatment and aftercare for all those affected by cancer. After two full years of the strategy, a total of £39 million of investment has been made and nearly one-third of the actions outlined in the strategy have been completed. The Scottish Government has also undertaken a range of actions to tackle known cancer risk factors, some of them highlighted this evening in the areas of diet and obesity, excessive alcohol consumption and smoking. Supporting our ambitions to improve cancer services for all those affected is the £41 million detect cancer early programme. Over the past six years, the programme has increased diagnostic capacity across Scotland and worked to raise awareness of the signs and symptoms of cancers. However, while we always seek to encourage early diagnosis wherever possible, we recognise that that is particularly challenging in the case of pancreatic cancer, where symptoms can often be difficult to diagnose. In addition to the detect cancer early programme, we are also updating the Scottish referral guidelines for suspected cancer, which are issued to GPs to help them to recognise cancer symptoms. Those guidelines, including the specific section on pancreatic cancer, are currently being revised with a view to publishing next year. We are also working to address waiting times, and the Ministerial Cancer Performance Delivery Group published its report in May this year with recommendations to improve waiting times for the diagnosis and treatment of those people with cancer in Scotland. Those recommendations will be taken forward with advice from an implementation group, and I am happy to record that, through their membership of the Scottish Cancer Coalition, third sector organisations such as Pancreatic Cancer UK and Pancreatic Cancer Scotland will have the opportunity to feed into the work of that group. We know that there is increasing pressures on the imaging services that are so critical to diagnosis and treatment and monitoring of cancers, particularly pancreatic cancer. That is why we are investing in more radiology training places, more radiology consultants and encouraging more recruitment into radiology vacancies across Scotland. The Scottish Government also recognises that further research is required on pancreatic cancer, and we have invested £650,000 to support the precision Panc study. That study aims to match patients to the most appropriate clinical trials through genetic analysis of their tumors. Along with an additional £10 million investment from cancer research UK, that study will help to improve our understanding of pancreatic cancer and will hopefully lead to more effective treatments. On the point that Miles Briggs raised, I welcome a letter to the Cabinet Secretary for Health and Sport on the issue that he raised about protected time for research. As we have heard, Pancreatic Cancer UK has issued a call to action through their faster treatment campaign, and Scottish Government officials will be meeting with Pancreatic Cancer UK in the coming months to discuss what actions can be taken to support that. The Scottish Government has written to the three regional cancer networks in Scotland in relation to publication of their clinical management guidelines and pathways for pancreatic cancer in order to provide patients and carers with greater understanding of the clinical decision-making processes. As I noted earlier, we have seen significant progress in relation to cancer. However, despite everything that we have achieved, we know that we must keep looking at what we can do better, how we should transform care, how we can equip ourselves to deliver even better health and social care services in the future. The actions outlined in the cancer strategy will assist with that, but it will also require us to move forward together. That was why it was so encouraging to hear such a collaborative and cohesive debate this evening, and we must work with our dedicated NHS professionals and researchers. However, just as importantly, we need to work with and listen to those people living with cancer, their carers, and the voluntary groups such as Pancreatic Cancer UK and Pancreatic Cancer Scotland. Once again, I thank them for the work that they do.